Cargando…
Risk factors of local recurrence after surgery in extraabdominal desmoid‐type fibromatosis: A multicenter study in Japan
This study was undertaken to clarify the risk factors, including the mutation status of CTNNB1, for the local recurrence after surgery of the rare disease desmoid‐type fibromatosis. It was designed as a multiinstitutional joint research project with 7 major centers in Japan participating. The commit...
Autores principales: | Nishida, Yoshihiro, Hamada, Shunsuke, Kawai, Akira, Kunisada, Toshiyuki, Ogose, Akira, Matsumoto, Yoshihiro, Ae, Keisuke, Toguchida, Junya, Ozaki, Toshifumi, Hirakawa, Akihiro, Motoi, Toru, Sakai, Tomohisa, Kobayashi, Eisuke, Gokita, Tabu, Okamoto, Takeshi, Matsunobu, Tomoya, Shimizu, Koki, Koike, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419055/ https://www.ncbi.nlm.nih.gov/pubmed/32539220 http://dx.doi.org/10.1111/cas.14528 |
Ejemplares similares
-
Diagnosis and treatment of extraabdominal desmoid fibromatosis
por: Ghanem, Mohamed, et al.
Publicado: (2014) -
Extraabdominal fibromatosis in retroperitoneal space
por: Kikkawa, Akira, et al.
Publicado: (2004) -
Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis
por: Sakai, Tomohisa, et al.
Publicado: (2022) -
Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis
por: Sakai, Tomohisa, et al.
Publicado: (2017) -
Efficacy of auranofin as an inhibitor of desmoid progression
por: Ito, Kan, et al.
Publicado: (2022)